本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2026/5/111 分钟阅读
Government Owned Inventions Available for License: Enhanced Tumor Reactivity of T Cells Lacking SIT1, LAX1 or TRAT1
本地自动翻译 · 来源原始语言
摘要
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is actively seeking potential licensees interested in further developing these inhibitory transmembrane adapter proteins as targets for T-cell immunotherapy for the treatment of cancer, infectious diseases, and autoimmune diseases.
来源原始语言: Federal Register — Health and Human Services打开原始公告 →